|
|
Arpida AG - Comparative Business Analysis Snapshot
Business Description
Arpida AG. The Group's principal activity is to discover and develop of efficacious anti-microbial drugs for the treatment of infectious diseases. The Group has a fully integrated platform for the discovery and development of drug candidates. The Group has operation in Switzerland, United Kingdom, Scandinavia, Benelux, France, Germany, Americas, Asia and Other.
Competitor Analysis
This analysis compares Arpida AG with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
